Elsevier Commits to Accelerate AI-Driven Science Across Europe

Elsevier, a global leader in advanced information and decision support in science and healthcare, today announced its pledge to the European Commission's AI in Science Enablers Initiative.

Elsevier's contribution spans complimentary access to its AI-powered research and clinical tools, funded research collaborations, and training for the next generation of AI-literate researchers and clinicians, reflecting the company's mission to help advance science and healthcare to advance human progress.

The pledge was announced at the AI in Science Summit in Dublin, which brought together over 1,000 participants from the research, technology, business, and policy communities to launch the Commission's initiative to mobilize private-sector and philanthropic support for European science.

Elsevier AI solutions

Elsevier will make available 4,000 complimentary licenses for European researchers, healthcare professionals and students:

• 1,000 LeapSpace™ licenses for early-career and senior researchers, alongside a proposed Europe-wide Challenge to be developed with the Commission. LeapSpace is a research-grade AI workspace that helps researchers carry out complex tasks across their complete workflows.

• 1,000 ClinicalKey AI licenses. ClinicalKey AI is an EHR and API-enabled clinical decision support tool designed to quickly surface the latest evidence at the point of care.

• 1,000 ClinicalKey Nursing AI licenses. ClinicalKey Nursing AI is a clinical AI tool built specifically for nurses and designed to support both point of care decision-making and professional growth across the nursing career journey.

• 1,000 Complete Anatomy licenses. Complete Anatomy is the world's most advanced 3D anatomy platform.

Research collaboration and training

• Alongside these licenses, Elsevier is committing an estimated €1m a year of in-kind support and funding to strengthen Europe's AI research talent pipeline and to advance responsible, AI-centered research:

• At least three new collaborations per year with European research institutions, drawing on in-kind support from Elsevier's data science, ethics and software development experts, alongside access to its content suite and knowledge discovery tools.

• Participation in the Horizon-funded AIRIS project, which supports AI-enabled hypothesis generation in biomedicine.

• Establishment of a new Centre on Hybrid Intelligence for Trustworthy Research, in partnership with the University of Amsterdam and Vrije Universiteit Amsterdam.

• Training and career development for approximately 10 PhD candidates, postdoctoral researchers and master’s students in AI per year, through programs across the company.

Kumsal Bayazit, CEO, Elsevier, said: “Europe's world-leading researchers and clinicians are working at the frontier of AI, and they need platforms and partnerships they can trust. Through this pledge, Elsevier is bringing the full breadth of its capabilities to that effort — funded collaborations, training for the next generation of scientists, and research-grade AI and clinical solutions for better outcomes. We're proud to support the European Commission's AI in Science Enablers Initiative and to help build an AI research ecosystem for Europe that is innovative, responsible, and sustainable.”

Elsevier will continue to work with the European Commission to refine the details of its pledge, including the scope of the LeapSpace Challenge, in the weeks following the Summit. To apply for complimentary access to Elsevier’s AI-powered research and clinical tools, please visit: www.elsevier.com/promotions/eu-ai-science-enablers-portal.

About the AI in Science Enablers Initiatives

The AI in Science Enablers Initiative is a European Commission initiative to maximize the impact of private-sector and philanthropic support for the European research community, and to make these initiatives as visible and accessible as possible to researchers and scientific organizations across Europe.

엘스비어 소개

엘스비어는 첨단 정보와 의사결정 지원 분야의 글로벌 선도 기업이다. 100년 넘게 과학과 헬스케어의 발전을 지원하며 인류 진보에 기여해 왔다. 전 세계 170개국에서 학계 및 기업 연구 커뮤니티와 의사, 간호사, 미래 의료 전문가, 교육자들이 수행하는 중요한 업무를 지원한다. 세계 최고 수준의 근거 기반 과학·의학 콘텐츠와 정밀 AI, 전문가 평가를 토대로 구축한 연구 및 임상 등급 솔루션을 제공하여 의미 있는 변화를 만들어가는 사람들에게 더 나은 성과를 거둘 수 있도록 돕는다. 또한 포용성과 지속가능성 증진에 앞장서며 엘스비어가 지원하는 커뮤니티와 협력한다. 엘스비어 재단(The Elsevier Foundationopens in new tab/window)은 전 세계의 연구 및 보건 파트너십을 지원한다.

엘스비어는 전문가 및 기업 고객에게 정보 기반 분석과 의사결정 도구를 제공하는 글로벌 기업 RELXopens in new tab/window의 일원이다. 자세한 내용은 www.elsevier.com에서 확인할 수 있으며, 소셜미디어 @elsevierconnect를 통해 최신 소식을 받아볼 수 있다.